Page 2 - Tau Program News Today

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $7.65 and traded as low as $7.61. Voyager Therapeutics shares last traded at $7.91, with a volume of 156,006 shares changing hands. Wall Street Analyst Weigh […]

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) CEO Alfred Sandrock sold 7,437 shares of the stock in a transaction on Monday, April 3rd. The shares were sold at an average price of $7.83, for a total value of $58,231.71. Following the completion of the sale, the chief executive officer now directly owns 214,618 shares of […]

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) CEO Alfred Sandrock sold 7,437 shares of Voyager Therapeutics stock in a transaction dated Monday, April 3rd. The stock was sold at an average price of $7.83, for a total value of $58,231.71. Following the completion of the transaction, the chief executive officer now owns 214,618 shares of […]

Voyager Therapeutics (NASDAQ:VYGR – Get Rating) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Friday. Separately, Oppenheimer initiated coverage on shares of Voyager Therapeutics in a research report on Thursday, March 9th. They issued an “outperform” rating and a $14.00 price target for […]

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) COO Robin Swartz sold 3,654 shares of the business’s stock in a transaction that occurred on Monday, March 20th. The shares were sold at an average price of $7.76, for a total value of $28,355.04. Following the completion of the sale, the chief operating officer now directly owns […]

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) COO Robin Swartz sold 1,527 shares of the business’s stock in a transaction on Monday, April 4th. The shares were sold at an average price of $8.25, for a total value of $12,597.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which […]

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) has received a consensus rating of “Buy” from the eight ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target […]

Brokerages expect that Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) will report earnings per share (EPS) of ($0.14) for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Voyager Therapeutics’ earnings. The lowest EPS estimate is ($0.56) and the highest is $0.64. Voyager Therapeutics posted earnings per share of ($0.58) […]